MHRA asks for views on proposed guidance to support the safe regulation of new personalised cancer therapies  

image_pdfimage_print

The draft MHRA guidance aims to clarify and streamline pathways for bringing these therapies through to patients, without compromising on robust safety principles

Leave a Reply

Your email address will not be published.